Case Reports in Cardiology最新文献_第4页

Successful Percutaneous Coronary Intervention in Chronic Total Occlusion after Coronary Perforation. 冠脉穿孔后慢性全闭塞经皮冠状动脉介入治疗成功。

IF 0.6

Case Reports in Cardiology Pub Date : 2023-01-01 DOI: 10.1155/2023/6640439

Luis A Areiza, Juan F Rodriguez

引用次数: 0

Successful Repair of TEF and DORV in a Child in a Resource-Limited Setting. 资源有限条件下儿童TEF和DORV的成功修复。

IF 0.6

Case Reports in Cardiology Pub Date : 2023-01-01 DOI: 10.1155/2023/1095670

Eru Sujakhu, Rajendra Shilpakar, Dhruba Shrestha

引用次数: 0

The Heart Block Hat-Trick: A Case of Alternating First-, Second-, and Third-Degree Heart Blocks. 心脏传导阻滞帽子戏法:一、二、三度心脏传导阻滞交替的案例。

IF 0.6

Case Reports in Cardiology Pub Date : 2023-01-01 DOI: 10.1155/2023/8664315

Nicholas Huerta, Salman Malik, Christopher Haas

引用次数: 0

Missed Connections: Identification of Atrial Septal Defect by MRI. 缺失连接:用MRI识别房间隔缺损。

IF 0.6

Case Reports in Cardiology Pub Date : 2023-01-01 DOI: 10.1155/2023/2393308

Timothy J O'Toole, Faisal Dadi, Patrick Kietrsunthorn, Jason Foerst, Ali Hama Amin

引用次数: 0

Balloon-Atrioseptostomy in Small Children Using an Embolectomy Catheter: Preliminary Data. 使用栓子切除导管的儿童球囊-房隔造口术:初步数据。

IF 0.6

Case Reports in Cardiology Pub Date : 2023-01-01 DOI: 10.1155/2023/9920336

R Dalla Pozza, M Hermann, N A Haas

引用次数: 0

Ischemia Possibly Associated with High Degree Atrioventricular Block. 缺血可能与高度房室传导阻滞有关。

IF 0.6

Case Reports in Cardiology Pub Date : 2023-01-01 DOI: 10.1155/2023/6676757

Dimitrios Siamkouris, Elmar Offers, Marc Schloesser, Gjoko Ilieski, Stergios Tzikas

引用次数: 0

Transvenous ICD Implantation into a Coronary Sinus Branch: A Safe and Feasible Alternative to Deliver ICD after Tricuspid Valve Reconstruction. 经静脉置入冠状窦支ICD:三尖瓣重建后安全可行的ICD替代方法。

IF 0.6

Case Reports in Cardiology Pub Date : 2023-01-01 DOI: 10.1155/2023/6646224

M Gruszczynski, A Müller-Burri, A Häussler, A Breitenstein, H Rodriguez Cetina Biefer, O Dzemali

引用次数: 0

Non-Iatrogenic Localized-Reentrant Figure of Eight Atrial Tachycardias in the Superior Vena Cava. 8例上腔静脉房性心动过速的非医源性定位再入图。

IF 0.6

Case Reports in Cardiology Pub Date : 2023-01-01 DOI: 10.1155/2023/5074946

Shota Tokuno, Kenjiro Miyamoto, Ryuichi Usui

引用次数: 0

The Role of RYR2 in Atrial Fibrillation. RYR2在房颤中的作用。

IF 0.6

Case Reports in Cardiology Pub Date : 2023-01-01 DOI: 10.1155/2023/6555998

Bernhard M Boehm, Jochen Gaa, Petra Hoppmann, Eimo Martens, Dominik S Westphal

{"title":"The Role of RYR2 in Atrial Fibrillation.","authors":"Bernhard M Boehm, Jochen Gaa, Petra Hoppmann, Eimo Martens, Dominik S Westphal","doi":"10.1155/2023/6555998","DOIUrl":"https://doi.org/10.1155/2023/6555998","url":null,"abstract":"Background. Atrial fibrillation (AF) is a common arrhythmia in elderly patients and is associated with increased risk of mortality. The pathogenesis of AF is complex and based on multiple genetic and environmental factors. Genome-wide association studies identified several loci in AF patients, indicating the complex genetic architecture of this disease. In rare cases, familial forms of AF have been described. Today, pathogenic variants in at least 11 different genes are associated with monogenic AF. Case presentation. The 37-year-old male patient presented to our emergency department with AF. At the age of 35, he had already been diagnosed with paroxysmal AF. Additionally, his 34-year-old brother had also been diagnosed with AF as well as nonobstructive hypertrophic cardiomyopathy. Moreover, the patient's father was diagnosed with AF in his twenties. Transthoracic echocardiography and cardiac MRI revealed a reduced systolic left ventricular ejection without any signs of hypertrophic cardiomyopathy. Genetic testing identified the heterozygous missense variants c.3371C > T, p.(Pro1124Leu) in RYR2 (NM_001035.3) and c.2524C > A, p.(Pro842Thr) in HCN4 (NM_005477.3) in the patient's and his brother's DNA. Discussion. This case of familial AF helps to strengthen the role of RYR2 as a disease gene in the context of AF. Although the variant in RYR2 needs to be classified formally as variant of unknown significance, we regard it as probably disease-causing due to the previously published data. As RYR2 has already been identified as a possible target for prevention and therapy of AF, the knowledge of variants in RYR2 might become even more crucial for individual molecular therapies in the future.","PeriodicalId":51760,"journal":{"name":"Case Reports in Cardiology","volume":"2023 ","pages":"6555998"},"PeriodicalIF":0.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10033205/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9245961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A Challenging Case of Genetically and Histologically Diagnosed Pulmonary Veno-Occlusive Disease with Extracorporeal Life Support and Redo Lung Transplantation. 一个具有挑战性的遗传和组织学诊断的肺静脉闭塞疾病体外生命支持和重做肺移植。

IF 0.6

Case Reports in Cardiology Pub Date : 2023-01-01 DOI: 10.1155/2023/4846338

Mohamed Laimoud, Ziyad Alanazi, Fayez Alahmadi, Abdullah Aldalaan

{"title":"A Challenging Case of Genetically and Histologically Diagnosed Pulmonary Veno-Occlusive Disease with Extracorporeal Life Support and Redo Lung Transplantation.","authors":"Mohamed Laimoud, Ziyad Alanazi, Fayez Alahmadi, Abdullah Aldalaan","doi":"10.1155/2023/4846338","DOIUrl":"https://doi.org/10.1155/2023/4846338","url":null,"abstract":"Background: Pulmonary veno-occlusive disease (PVOD) is a rare form of pulmonary arterial hypertension characterized by diffuse venous vasculopathy and increased pulmonary vascular resistance resulting in right-sided heart failure. Case Presentation. A 22-year-old female patient started to have dyspnea with minimal effort and was diagnosed to have pre-capillary pulmonary hypertension (PH) with right-sided heart failure. Initially, she was diagnosed to have idiopathic PH. She developed life-threatening pulmonary oedema and cardiogenic shock after pulmonary vasodilator therapy. A genetic study was done and revealed the eukaryotic translation initiation factor 2 alpha kinase 4 (EIF2AK4) gene on chromosome 15, which was diagnostic to heritable PVOD. After failure to achieve hemodynamic stabilization with conventional cardiopulmonary support measures, extracorporeal membrane oxygenation (ECMO) supported her till bilateral lung transplantation, which was unfortunately complicated by acute graft rejection. After a prolonged intensive care unit stay with 4-month ECMO support, the second bilateral lung transplantation was done, and the patient survived and was discharged.Conclusions: Clinical recognition of PVOD is crucial due to its challenging diagnosis, need for genetic study, rapid deterioration with pulmonary vasodilators, and bad prognosis. Lung transplantation is the definitive treatment for eligible candidates.","PeriodicalId":51760,"journal":{"name":"Case Reports in Cardiology","volume":"2023 ","pages":"4846338"},"PeriodicalIF":0.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465249/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10118759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0